ContractMaster Clinical Trial Agreement • August 29th, 2023
Contract Type FiledAugust 29th, 2023AMENDMENT NO. 1to theMaster Clinical Trial Agreement dated as of 23.05.2016 (“Agreement”) DODATEK Č.1 k Rámcové smlouvě o klinickém hodnocení podepsané dne 23.5.2016(dale jen “Smlouva) by and between Boehringer Ingelheim RCV GmbH & Co KGDr. Boehringer-Gasse 5-11,1121 Vienna AustriaVAT-ID-No.: ATU 64226215(hereinafter referred to as "Sponsor") mezi Boehringer Ingelheim RCV GmbH & Co KGDr. Boehringer-Gasse 5-11,1121 Vídeň, RakouskoDIČ: ATU 64226215(dále Jen „Zadavatel“) and Institute of Rheumatology, Na Slupi 4, 128 50, Prague 2 Responsible unit: Department of Clinical TrialsVAT-ID-No. resp. Taxpayer Ident. No.:CZ000237238(hereinafter referred to as "Institution") a Revmatologický ústav, Na Slupi 4, 128 50, Praha 2 Odpovědný útvar:Oddělení Klinických Hodnocení DIČ/IČ: CZ00023728(Dále Jen „Zdravotnické Zařízení“) WHEREAS, Sponsor and Institution have entered into the Agreement. WHEREAS, Sponsor and Institution desire to continue the successful relationship by altering the Agreement in ce